Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs
- 1 March 2001
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 4 (3) , 268-274
- https://doi.org/10.1038/85115
Abstract
Many peptides and transmitters found within the brain also have peripheral sites of action. We now demonstrate that the brain releases functionally active neurotransmitters/neuromodulators directly from the brain into the blood through a saturable P-glycoprotein (Pgp) transport system. Downregulating Pgp1 expression with antisense reduced the brain-to-blood transport of morphine, β-endorphin and other opioids. Lowering Pgp expression significantly enhanced systemic morphine analgesia and prevented tolerance, but diminished the analgesic activity of centrally administered morphine, implying that supraspinal analgesia resulted from a combination of central and peripheral mechanisms activated by morphine transported from the brain to the blood. Similarly, mice with a disruption of the Mdr1a gene were more sensitive to systemic morphine and less sensitive to morphine given centrally. This ability of the Pgp transport system to pump functionally active compounds from the brain to periphery defines a potentially important mechanism for the central nervous system to modulate peripheral systems.Keywords
This publication has 37 references indexed in Scilit:
- Increased brain P-glycoprotein in morphine tolerant ratsLife Sciences, 1999
- The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) miceBritish Journal of Pharmacology, 1999
- Role of blood‐brain barrier P‐glycoprotein in limiting brain accumulation and sedative side‐effects of asimadoline, a peripherally acting analgaesic drugBritish Journal of Pharmacology, 1999
- Transport of the δ-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood–brain barrier involves transcytosis1Journal of Pharmaceutical Sciences, 1999
- Enhanced Antinociception of the Model Opioid Peptide [D-Penicillamine2,5] Enkephalin by P-Glycoprotein ModulationPharmaceutical Research, 1999
- Passage of peptides across the blood-brain barrier: Pathophysiological perspectivesLife Sciences, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Endogenous peptide Tyr‐Pro‐Trp‐Gly‐NH2 (Tyr‐W‐MIF‐1) is transported from the brain to the blood by peptide transport system‐1Journal of Neuroscience Research, 1993
- Elevation of tumor necrosis factor in head injuryJournal of Neuroimmunology, 1990
- Saturable transport of peptides across the blood-brain barrierLife Sciences, 1987